Intimation of trading approval obtained from Stock Exchanges for 81,24,698 Equity Shares of RS. 10/- each issued pursuant to the approved Scheme of Amalgamation
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has received trading approval from the Stock Exchanges for 81,24,698 equity shares of Rs. 10 each. These shares were issued to shareholders as part of a previously approved Scheme of Amalgamation. With this approval, these shares will now be tradable on the exchanges. This is a procedural step that follows the final approval of the merger scheme.
Existing shareholders may see increased share supply in the market, which could create short-term selling pressure. However, this is a routine post-merger step and does not change the fundamental value of the company.